Company Filing History:
Years Active: 2016
Title: Renate Janssen: Innovator in Vaccine Development
Introduction
Renate Janssen is a prominent inventor based in Hannover, Germany. She has made significant contributions to the field of biotechnology, particularly in vaccine development. Her innovative work has led to the creation of a novel method that enhances the efficacy of vaccine strains.
Latest Patents
Renate Janssen holds one patent that focuses on a unique method for growing attenuated mutant strains lacking galactose epimerase activity. This method involves culturing the strains without adding glucose to the medium during fermentation, ensuring that the starting glucose amount is depleted before reaching the stationary phase. The invention also includes attenuated mutant strains that can be obtained through this method, specifically those harboring a recombinant DNA molecule encoding a VEGF receptor protein for use as a vaccine.
Career Highlights
Renate Janssen is associated with Vaximm AG, a company dedicated to advancing immunotherapy and vaccine technologies. Her work at Vaximm AG has positioned her as a key player in the development of innovative vaccine solutions.
Collaborations
Renate has collaborated with notable colleagues, including Heinz Lubenau and Holger Siede, who have contributed to her research endeavors.
Conclusion
Renate Janssen's innovative approach to vaccine development exemplifies her commitment to advancing biotechnology. Her contributions are paving the way for new therapeutic solutions in the field of immunology.